Company Immunovia AB

Equities

IMMNOV

SE0006091997

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Stockholm Other stock markets 08:59:36 02/05/2024 pm IST			5-day change	1st Jan Change
1.844 ^SEK	-9.16%		-3.66%	+4.06%

29/04	Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
29/04	Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina	CI

Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunoviaâs test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Number of employees: 11

SEK in Million	2021	Weight	2022	Weight	Delta
Non-invasive Blood Tests 100.0 %	1	100.0 %	1	100.0 %	+35.66%

SEK in Million	2021	Weight	2022	Weight	Delta
Sweden 59.1 %	1	59.2 %	1	59.1 %	+35.40%
United States 40.9 %	0	0.0 %	0	40.9 %	-

Managers	Title	Age	Since
Jeff Borcherding CEO	Chief Executive Officer	-	-
Karin Almqvist Liwendahl DFI	Director of Finance/CFO	62	01/22/01
Karl Stone COO	Chief Operating Officer	61	01/23/01
Lara Sucheston-Campbell CTO	Chief Tech/Sci/R&D Officer	-	01/23/01
Linda Mellby CTO	Chief Tech/Sci/R&D Officer	-	-
Thomas C. King CTO	Chief Tech/Sci/R&D Officer	66	01/17/01
Rolf Bertil Ehrnström CTO	Chief Tech/Sci/R&D Officer	71	01/13/01
Philipp Mathieu BRD	Director/Board Member	46	20/22/20
Tobias Bülow IRC	Investor Relations Contact	-	15/22/15
Cindy Callahan SAM	Sales & Marketing	-	-

Members of the board	Title	Age	Since
Hans Olof Gunnar Johansson BRD	Director/Board Member	70	09/16/09
Peter Andersen CHM	Chairman	67	01/20/01
Michael Löfman BRD	Director/Board Member	-	22/23/22
Martin Møller BRD	Director/Board Member	49	01/21/01
Eric Krafft BRD	Director/Board Member	49	01/22/01
Philipp Mathieu BRD	Director/Board Member	46	20/22/20

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	45,287,498	34,200,305 ( 75.52 %)	0	75.52 %

Name	Equities	%	Valuation
Ranny Davidoff 2.724 %	1,233,689	2.724 %	157 838 kr
Coeli Asset Management AB 0.6787 %	307,371	0.6787 %	39 325 kr
Banor Capital Ltd. 0.4416 %	200,000	0.4416 %	25 588 kr
Storebrand Asset Management AS 0.1027 %	46,499	0.1027 %	5 949 kr
Erik Penser Bank AB (Invt Mgmt) 0.0338 %	15,301	0.0338 %	1 958 kr
Case Kapitalförvaltning AB 0.004997 %	2,263	0.004997 %	290 kr

Immunovia AB

Scheelevägen 8 Medicon Village

223 81, Lund

+46 4 62 75 60 00

http://www.immunovia.se

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
IMMUNOVIA AB	+4.06%	8.38M
SARTORIUS AG	-15.52%	18.54B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+17.00%	1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.51%	1.66B
BIOTAGE AB	+25.21%	1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.90%	989M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.76%	896M
REVENIO GROUP OYJ	-5.01%	744M
VAREX IMAGING CORPORATION	-19.80%	673M
CELLAVISION AB	+7.31%	490M

Medical Diagnostic & Testing Equipment